MORF
Price
$26.59
Change
+$0.81 (+3.14%)
Updated
Dec 7, 6:59 PM EST
82 days until earnings call
ORMP
Price
$2.25
Change
+$0.05 (+2.27%)
Updated
Dec 7, 6:59 PM EST
82 days until earnings call
Ad is loading...

Compare predictions MORF vs ORMP

Header iconMORF vs ORMP Comparison
Open Charts MORF vs ORMPBanner chart's image
Morphic Holding
Price$26.59
Change+$0.81 (+3.14%)
Volume$295.2K
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.25
Change+$0.05 (+2.27%)
Volume$91.08K
CapitalizationN/A
View a ticker or compare two or three
MORF vs ORMP Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
MORF vs. ORMP commentary
Dec 08, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MORF is a Buy and ORMP is a Hold.

COMPARISON
Comparison
Dec 08, 2023
Stock price -- (MORF: $26.54 vs. ORMP: $2.26)
Brand notoriety: MORF and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MORF: 58% vs. ORMP: 72%
Market capitalization -- MORF: $1.16B vs. ORMP: $88.75M
MORF [@Biotechnology] is valued at $1.16B. ORMP’s [@Biotechnology] market capitalization is $88.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MORF’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 1 green FA rating(s).

  • MORF’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 1 green, 4 red.
According to our system of comparison, ORMP is a better buy in the long-term than MORF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MORF’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 7 bullish TA indicator(s).

  • MORF’s TA Score: 5 bullish, 4 bearish.
  • ORMP’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than MORF.

Price Growth

MORF (@Biotechnology) experienced а +11.98% price change this week, while ORMP (@Biotechnology) price change was +1.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10152.36%. For the same industry, the average monthly price growth was +6.66%, and the average quarterly price growth was +25.39%.

Reported Earning Dates

MORF is expected to report earnings on Feb 28, 2024.

ORMP is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (+10152.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MORF with price predictions.
OPEN
A.I.dvisor published
a Summary for ORMP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MORF($1.16B) has a higher market cap than ORMP($88.7M). MORF YTD gains are higher at: -0.785 vs. ORMP (-81.214). ORMP has higher annual earnings (EBITDA): -15.96M vs. MORF (-154.78M). MORF has more cash in the bank: 725M vs. ORMP (175M). MORF has less debt than ORMP: MORF (2.73M) vs ORMP (76M). MORF has higher revenues than ORMP: MORF (6.66M) vs ORMP (2.02M).
MORFORMPMORF / ORMP
Capitalization1.16B88.7M1,304%
EBITDA-154.78M-15.96M970%
Gain YTD-0.785-81.2141%
P/E RatioN/AN/A-
Revenue6.66M2.02M329%
Total Cash725M175M414%
Total Debt2.73M76M4%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MORFORMP
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOF0.08N/A
+4.43%
Blue Biofuels
MSOCX20.530.16
+0.79%
Morgan Stanley Inst International Opp C
EISAX20.620.10
+0.49%
Carillon ClariVest Intl Stock A
YAFIX19.80N/A
N/A
AMG Yacktman Focused I
PEGRY18.80-0.18
-0.95%
Pennon Group plc

MORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MORF has been loosely correlated with ICPT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MORF jumps, then ICPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MORF
1D Price
Change %
MORF100%
+2.95%
ICPT - MORF
52%
Loosely correlated
N/A
ORMP - MORF
45%
Loosely correlated
+2.73%
AXON - MORF
43%
Loosely correlated
+1.29%
EDIT - MORF
42%
Loosely correlated
-1.94%
ARRY - MORF
42%
Loosely correlated
+0.38%
More